To transform world class cancer research into new cancer treatment - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

To transform world class cancer research into new cancer treatment

Description:

To transform world class cancer research into new cancer treatment ... the capacity to run clinical trials and reduce the time needed to run each trial. ... – PowerPoint PPT presentation

Number of Views:49
Avg rating:3.0/5.0
Slides: 21
Provided by: AS151
Category:

less

Transcript and Presenter's Notes

Title: To transform world class cancer research into new cancer treatment


1
  • - To transform world class cancer research into
    new cancer treatment
  • Jónas Einarsson, Chairman of Oslo Cancer Cluster

2
Agenda
  • Vision and purpose for Oslo Cancer Cluster
  • OCC as an accellerator of development of new
    cancer diagnostics and treatment

3
Our Vision for Oslo Cancer Cluster- Our vision
is a statement of what we aspire to, why we exist
and the impact we would like to have on society.
  • To transform world class cancer research into
    new cancer diagnostics and treatment and thereby
    improve the lives of
  • cancer patients.
  • We aspire to be regarded as the most innovative
    cluster for cancer diagnostics and treatment in
    Europe.

4
Purpose for Oslo Cancer Cluster- Our purpose
describes what we will do to achieve our vision
Through partnership between life science
industry, research institutions, university
hospitals, government and the Norwegian Cancer
Society ,the cluster will accellerate the
development of innovative cancer diagnostics and
treatment. We work to ensure access to new
treatments developed, in order to improve the
lives of cancer patients.
5
Members of Oslo Cancer Cluster
  • 6 Global pharma companies
  • 9 Norwegian listed Biotech companies
  • 16 Norwegian Start-up Biotech companies
  • 7 RD facilitators
  • New members Kreftforeningen and Ullevål
    Universitetssykehus
  • Employees 1600
  • Turnover 5,7 billion NOK
  • RD 1,0 billion NOK
  • 63 oncology projects in pipeline

6
The Academic Institutions
  • 2 Universities
  • 4 University Hospitals
  • 3 Research Institutions
  • 2 Tech transfer offices
  • 80 of all cancer research in Norway is
    performed in these institutions

7
The value creating cycle inside the cluster
8
Case Innovative blood test to detect breast
cancer in its earliest stages could be made
available in 2009 - developed in the cluster in
cooperation between Radiumhospitalet and Diagenic
9
Case Drug delivery system PCI Biotech developed
at Radiumhospitalet
  • The PCI technology has a potential to improve the
    effect both of existing drugs and of emerging
    treatments such as gene therapy and other
    therapies based on nanotechnology or on
    biotechnological principles.

PCI is a technology for light-directed drug
delivery, used to enhance the effect of drugs by
targeted illumination of the diseased areas of
the body.
10
Oslo Cancer Cluster Norwegian Centre of
Expertise
  • Norway has appointed nine strong clusters
    consisting of world class enterprises in their
    field. Together, these clusters of excellence
    make the NCE programme.The nine clusters have
    been selected in strong competition with several
    expert environments in Norway.
  • Norwegian Centres of Expertise (NCE) was launched
    in 2006 aiming at strengthening innovation and
    internationalisation processes in clusters based
    on collaboration between companies, RD and
    educational institutions and public sector.
  • The programme is targeted at well-established
    clusters with clear strategies and a high
    potential for further innovation-based growth.
    The leading actors shall be a group of companies
    with a long-term commitment to develop the
    cluster.

Behind the NCE are SIVA, The Research Council of
Norway and Innovation Norway.
11
(No Transcript)
12
Agenda
  • Vision and purpose for Oslo Cancer Cluster
  • OCC as an accellerator of development of new
    cancer diagnostics and treatment

13
Strategy for Oslo Cancer Cluster - NCE
  • We will transform world class cancer research
    into new cancer diagnostics and treatment,
    through partnership between life science
    industry, research institutions, university
    hospitals, government and the Norwegian Cancer
    Society
  • Our core initiatives prioritized by our member
    companies are
  • We will create an efficient system for clinical
    trials (phase 1-3) in partnership between
    university hospitals, government and the life
    science industry.
  • We will proactively work with the government in
    order to achieve internationally competitive
    legislation for the life science industry in
    Norway.
  • We will with our partners build an Innovationpark
    which includes cancer research, biobanking,
    cancer registry, clinical trials facility, life
    science industry and high school science
    education, all in the same building adjacent to
    the comprehensive cancer center (CCC) at the
    Norwegian Radium Hospital.

14
Strategy for Oslo Cancer Cluster - NCE
  • We will activate research collaborations and
    innovation networks between academia and life
    science industry through frequent meeting points
    in Oslo Cancer Cluster.
  • 5. We will alongside our collaborators, work for
    biotech capital development, and raise the
    profile for investments in cancer diagnostics and
    therapeutic companies in Norway.

15
Key Performance Indicators for Oslo Cancer
Cluster
  • Number of preclinical and clinical projects
  • Number of clinical trials
  • Number of patents
  • Number of new established SME
  • Workforce in the cluster
  • Market value of companies locally

16
Oslo Cancer Cluster will create an efficient
system for clinical trials (phase 1-3) in
partnership between university hospitals,
government and the life science industry.
17
Oslo Cancer Cluster Innovationpark
  • By integrating business with research and
    education, Oslo Cancer Cluster Innovation Park in
    collaboration with Ullern high school, The
    University of Oslo, The Norwegian Radium
    Hospital, aims to create Norways leading
    environment for education and innovation in the
    fields of biotechnology and life sciences.

18
Oslo Cancer Cluster Innovationpark
  • Oslo Cancer Cluster Innovation Park (OCCI) aims
    to
  • Fulfill development projects between university/
    hospital/business
  • Promote innovation and creativity and support the
    development of ideas into products and commercial
    enterprises
  • Develop and support biotechnology start-up
    companies through an incubator and an advisory
    board
  • Channel internal, external and international
    financing of development projects and new
    enterprises into the industrial cluster
  • Strengthen the training, education, specializing
    and availability of competent personnel in the
    fields of science, life sciences, medicine and
    biotechnology

19
We will activate research collaborations and
innovation networks between academia and life
science industry through frequent meeting points
in the cluster
20
.Men det er ikke alle handelsområder som
skaper ny innovasjon)
Write a Comment
User Comments (0)
About PowerShow.com